SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-004193
Filing Date
2022-11-29
Accepted
2022-11-29 08:05:12
Documents
4
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 6-K zk2228829.htm 6-K 11124
2 EXHIBIT 99.1 exhihit_99-1.htm EX-99.1 321808
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99 607004
4 image0.jpg GRAPHIC 89710
  Complete submission text file 0001178913-22-004193.txt   1064438
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 221428369
SIC: 2834 Pharmaceutical Preparations